Magda Michna

Corporate Officer/Principal at STAAR SURGICAL COMPANY

Net worth: 1 M $ as of 30/06/2026

50 year

Health Technology

Consumer Services

Profile

Magda Michna is currently Chief Development Officer at STAAR Surgical Co., starting in 2025.
Formerly, Dr. Michna was Head-Chief Global Clinical & Medical Officer at AcuFocus, Inc. from 2018 to 2023 and Chief Clinical Officer at Presbia PLC from 2012 to 2017.
Education includes undergraduate and doctorate degrees from the University of Melbourne.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
STAAR SURGICAL COMPANY 0.09%	15/05/2026	42,783 ( 0.09% )	1 M $	30/06/2026

Magda Michna active positions

Companies	Position	Start
STAAR SURGICAL COMPANY	Corporate Officer/Principal	18/03/2025

All active positions of Magda Michna

Former positions of Magda Michna

Companies	Position	End
AcuFocus, Inc. AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device	Chief Tech/Sci/R&D Officer	01/01/2023
PRESBIA PLC	Chief Tech/Sci/R&D Officer	02/01/2017

See the detail of Magda Michna's experience

Training of Magda Michna

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Magda Michna's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
STAAR Surgical Co. STAAR Surgical Co. Medical SpecialtiesHealth Technology Designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye	Health Technology
AcuFocus, Inc. AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device	Health Technology
University of Melbourne University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Presbia PLC Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes Presbia Flexivue Microlens	Health Technology